BTEC Principal Healthcare Innovators ETF
Quote as of Jul 31, 2024 20:00 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 39.09 | Day Range | 39.42 – 39.62 |
| 52-Week Range | 25.66 – 41.10 | Volume | 6.42K |
| Avg Volume | 1.78K | AUM | $16.2M (Aug 26, 2026) |
| Expense Ratio | 0.42% | Yield (TTM) | — |
| NAV | 39.41 | Premium/Discount | +0.20% indicative |
| Inception | Aug 22, 2016 | Holdings | 3 |
| Issuer | Principal Funds | Exchange | NASDAQ |
| Category | Biotech | Index Tracked | Not stated in source data |
| CUSIP | 74255Y409 | ISIN | US74255Y4098 |
| Management | Not stated in source data | ||
About this ETF
Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies in the healthcare sector. It invests significantly in early-stage companies within the healthcare equipment and supplies, pharmaceuticals, biotechnology, and life sciences industries that are not yet consistently profitable.
Description from the fund data provider · profile as of Aug 26, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | +6.96% | +9.12% | +8.46% | +8.70% | +18.51% | -11.36% | +3.33% | — | +5.65% |
| Total return | +6.96% | +9.12% | +8.46% | +8.70% | +18.52% | -11.08% | +3.61% | — | +5.85% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Aug 07, 2024. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.42% | Annual cost of a $10,000 investment | $42.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Mar 31, 2026 — portfolio reporting date from the data provider; holdings are not live positions. 3 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | US DOLLAR | — | 99.89% | 16.13M | $16.1M |
| 2 | SCILEX HOLDING CO COMMON STOCK USD.0001 | SCLX | 0.09% | 10.08K | $13.8K |
| 3 | CONTRA CHINOOK THERAPE COMMON STOCK | — | 0.02% | 9.49K | $3.8K |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | — | Paid (last 12 months) | — |
| Frequency | Annual | SEC yield | Not provided by our data source — see the issuer page |
| Last ex-date | Dec 29, 2021 | Last payment | $0.4530 (Jan 03, 2022) |
| Growth 1Y | — | Growth 3Y / 5Y (ann.) | — / — |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Dec 29, 2021 | Dec 30, 2021 | Jan 03, 2022 | $0.4530 |
| Dec 17, 2020 | Dec 18, 2020 | Dec 22, 2020 | $0.2154 |
| Dec 15, 2017 | Dec 18, 2017 | Dec 20, 2017 | $0.0510 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
Liquidity
| Volume today | 6.42K | Average volume | 1.78K |
| AUM | $16.2M | Premium/Discount | +0.20% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV — an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source — review them before investing.
Latest News for BTEC
No articles mention this fund directly in the last 7 days — showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.